怀孕期间的肥胖和喘:系统性审查和元分析
Hirotaka Matsuzaki1, Shinya Matsuzaki2,3,4, Yutaka Ueda5,4
1Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
概括
肥胖会增加孕妇患喘和失控喘的风险. 它进一步增加了高血压疾病,妊娠期糖尿病,胎儿生长限制,早产和喘患者的剖腹产的风险.
科学领域:
- 产科和妇科 产科和妇科
- 肺部病理学 肺部病理学
- 公共卫生 公共卫生
背景情况:
- 喘是一种常见的呼吸系统疾病,可以影响孕妇.
- 肥胖是一个日益严重的公共卫生问题,对孕产妇和胎儿的健康有潜在的影响.
研究的目的:
- 评估肥胖对怀孕期间喘患病率和严重程度的影响.
- 评估肥胖如何影响喘孕妇的产科和分娩结果.
主要方法:
- 按照PRISMA指南进行了系统审查和元分析.
- 从四个公共搜索引擎收集和分析到2024年3月31日的数据.
- 包括11项研究,涉及超过7700万名孕妇患者.
主要成果:
- 肥胖与孕妇患喘和不受控制的喘的几率增加有关.
- 患有喘的孕妇有更高的妊娠高血压疾病 (HDP),妊娠糖尿病 (GDM),胎儿生长限制 (FGR),早产 (PTB) 和剖腹产 (CD) 的风险.
- 在患有喘的孕妇中,肥胖独立增加了HDP,GDM和CD的风险.
结论:
- 患有喘的怀孕与不良的产科和分娩结果有关.
- 肥胖加剧了这些风险,特别是在HDP,GDM和CD.
- 控制肥胖对于改善患有喘的孕妇的结果至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
246
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
246
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
374
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
374
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


